Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 643
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07783074 FIDO — Fatigue Investigation Using Digital Outcomes |
FIDO — Fatigue Investigation Usin… | SEP | À vérifier | RECRUITING | En attente / non publié | Liliana Barrios | Switzerland · Bellevue Medical Group - Neurozentrum S… | 2026-05-26 → 2028-05-01 | Ouvrir |
| NCT07224373 ZENITH — An Open-label Study of AZD0120 in Adults With Multiple Scleros… |
AZD0120 - Regimen 1 | SEP | Phase 1 | RECRUITING | En attente / non publié | AstraZeneca | United States, Australia, Canada, Germany, United Kin… | 2025-12-09 → 2028-12-12 | Ouvrir |
| NCT07663266 Development of Pain Management JITAI Content in Multiple Sclerosis and … |
Development of Pain Management JI… | SEP | À vérifier | COMPLETED | En attente / non publié | University of Michigan | United States · University of Michigan, Ann Arbor, Un… | 2026-05-15 → 2026-07-28 | Ouvrir |
| NCT07786506 TMS-SPASMS — Intermittent Theta-Burst Stimulation for Lower-Limb Spasti… |
Active Intermittent Theta-Burst S… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Comenius University | Slovakia · 2nd Department of Neurology, Faculty of Me… | 2026-08-10 → 2026-10-31 | Ouvrir |
| NCT07786987 CEW-MS — Cone Evasion Walk Test in Multiple Sclerosis |
CEW-MS — Cone Evasion Walk Test i… | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Hacettepe University | Turkey (Türkiye) · Erciyes University Faculty of Medi… | 2026-10-01 → 2027-09-30 | Ouvrir |
| NCT07788573 The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclero… |
The Role of the FCRL5 Protein in … | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Université Catholique de Louvain | Belgium · Université Catholique de Louvain, Brussels,… | 2026-08 → 2029-12-31 | Ouvrir |
| NCT07753928 PENTAGON — MS-Related Disability Worsening and Thalamic Volume Loss |
Disease-Modifying Therapies (DMTs) | SEP | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | SetPoint Medical Corporation | Germany · Multiple Faculties, Multiple Locations, Ger… | 2022-07-01 → 2033-06-30 | Ouvrir |
| NCT06846281 Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in… |
Remibrutinib oral treatment | SEP | Phase 3 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Belgium, Brazil,… | 2025-06-23 → 2031-06-25 | Ouvrir |
| NCT05409508 COREVALS — Psychological Management by Meditation of Full COnscience in… |
COREVALS — Psychological Manageme… | Sclérose latérale amyotrophique | Non applicable | WITHDRAWN | En attente / non publié | University Hospital, Angers | Non communiqué | 2022-05 → 2023-06 | Ouvrir |
| NCT06220201 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels… |
CC-97540 | Myasthénie | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Juno Therapeutics, Inc., a Bristo… | United States, Belgium, France, Germany, Spain, Unite… | 2024-03-28 → 2027-07-15 | Ouvrir |
| NCT06685848 Comparison of Hemanext ONE® System and Conventional Red Blood Cell Tran… |
Hemanext ONE system | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Hemanext | United States, Norway · Duke University Health System… | 2024-11-29 → 2028-08 | Ouvrir |
| NCT07718542 PEPSY — Prognosis of Epilepsy With Post-traumatic Stress Disorder and S… |
PEPSY — Prognosis of Epilepsy Wit… | Épilepsie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assistance Publique Hopitaux De M… | Non communiqué | 2026-09 → 2031-05 | Ouvrir |
| NCT07732907 Risk of Progressive Multifocal Leukoencephalopathy Among Patients With … |
Ozanimod | SEP | À vérifier | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States · Bristol Myers Squibb, Lawrenceville, … | 2026-06-04 → 2041-07-31 | Ouvrir |
| NCT05380856 Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Se… |
Turning ON the neuromodulator | SEP | Non applicable | RECRUITING | En attente / non publié | Odense University Hospital | Denmark · Odense University Hospital, Odense, Denmark | 2023-09-26 → 2027-03-01 | Ouvrir |
| NCT07225504 REMASTER — A Study to Evaluate the Efficacy and Safety of Remibrutinib … |
Remibrutinib (Blinded) | SEP | Phase 3 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Austria, Belgium… | 2025-11-11 → 2034-01-02 | Ouvrir |
| NCT06925022 ADVICE Phase 1 — Educational Programs Based on Healthy Habits to Improv… |
ADVICE Phase 1 — Educational Prog… | SEP | Non applicable | COMPLETED | En attente / non publié | Universidad de Almeria | Spain · Hospital Universitario Virgen de la Arrixaca,… | 2024-12-15 → 2026-06-30 | Ouvrir |
| NCT06864936 Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatmen… |
Ublituximab | SEP | Non applicable | RECRUITING | En attente / non publié | TG Therapeutics, Inc. | United States · University of Maryland, Baltimore, Ba… | 2026-05-01 → 2028-01-30 | Ouvrir |
| NCT02804594 A Study of Oxidative Pathways in MS Fatigue |
N-acetyl cysteine | SEP | Phase 2 | COMPLETED | En attente / non publié | University of California, San Fra… | United States · University of California San Francisc… | 2016-10-01 → 2018-06-01 | Ouvrir |
| NCT04544436 MUSETTE — A Study to Evaluate the Efficacy, Safety and Pharmacokinetics… |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Belgium, Brazil,… | 2020-11-26 → 2028-08-31 | Ouvrir |
| NCT05344469 AIOLOS — A NIS Evaluating Various Injectable and Oral Treatments in Pat… |
AIOLOS — A NIS Evaluating Various… | SEP | À vérifier | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Germany · Novartis Investigative Site, Aalen, Germany… | 2022-05-10 → 2029-05-30 | Ouvrir |
| NCT07501520 HistaMed-MS — Effect of Low Histamine-Based Modified Mediterranean Diet… |
HistaMed-MS — Effect of Low Hista… | SEP | Non applicable | COMPLETED | En attente / non publié | Firat University | Turkey (Türkiye) · Firat University Hospital, Neurolo… | 2024-06-15 → 2025-06-10 | Ouvrir |
| NCT07738978 Understanding and Enhancing Human Health and Movement |
Neural Prosthesis | SEP | Non applicable | RECRUITING | En attente / non publié | Louis Stokes VA Medical Center | United States · Louis Stokes Cleveland VA Medical Cen… | 2021-03-21 → 2034-03-21 | Ouvrir |
| NCT07736482 Relationship Between Single- and Dual-Task Obstacle Crossing Performanc… |
Relationship Between Single- and … | SEP | À vérifier | RECRUITING | En attente / non publié | Afyonkarahisar Health Sciences Un… | Turkey (Türkiye) · Afyonkarahisar Health Sciences Uni… | 2026-03-20 → 2027-02-20 | Ouvrir |
| NCT07738120 Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: … |
Immersive Virtual Reality and Exe… | SEP | Non applicable | RECRUITING | En attente / non publié | University of Vigo | Spain · University of Vigo, Pontevedra, Spain | 2025-10-06 → 2026-08-07 | Ouvrir |
| NCT07743281 A Study of Treatment Patterns and Annualized Relapse Rate in Multiple S… |
A Study of Treatment Patterns and… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States · Novartis, East Hanover, United States | 2025-03-10 → 2025-07-30 | Ouvrir |